Novo Nordisk A/S (NYSE:NVO)

46.55
Delayed Data
As of 9:23am ET
 -0.53 / -1.13%
Today’s Change
36.39
Today|||52-Week Range
58.37
-13.27%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
AssetsCash2.4B3.3B3.0B3.0B
 
 
 
 
 
Short Term Investment Cash-332.9M507.0M-111.8M-261.9M
 
 
 
 
 
Cash & Short Term Investments2.6B3.5B3.4B3.4B
 
 
 
 
 
 
ReceivablesReceivables3.2B2.8B2.8B3.8B
 
 
 
 
 
 
InventoriesInventories2.2B2.3B2.4B2.5B
 
 
 
 
 
 
Current AssetsOther Current Assets0.00434.1M418.1M0.00
 
 
 
Current Assets8.0B9.0B9.1B9.7B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross------10.4B
 
 
Depreciation-------4.7B
 
 
Intangible Assets398.6M406.0M415.4M536.3M
 
 
 
 
 
Other Assets398.6M406.0M415.4M536.3M
 
 
 
 
 
Total Assets13.6B15.0B15.6B16.5B
 
 
 
 
 
 
LiabilitiesAccounts Payable544.0M653.0M719.6M904.8M
 
 
 
 
 
Short Term Debt88.2M258.2M41.3M273.2M
 
 
 
 
 
Accrued Expenses------48.4M
 
 
Other Current Liabilities5.8B5.2B5.5B5.7B
 
 
 
 
 
Other Liabilities7.0B6.7B7.2B7.6B
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes-380.4M-267.7M-235.6M-176.6M
 
 
 
 
 
Total Liabilities7.8B7.6B8.1B8.5B
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity5.8B7.4B7.5B8.0B
 
 
 
 
 
Total Shareholder Equity5.8B7.4B7.5B8.0B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.0B2.0B2.0B1.9B
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.